Immuno-Oncology

Syngene reports solid Q4 growth and ends the year on a strong note

Q4 revenue up 13% to Rs. 628 Cr, PAT up 20% to Rs 120 Cr; full year revenue up 10%…

5 years ago

First Russian original PD-1 inhibitor got approved

Saint Petersburg, April 22, 2020: On April 20, the Russian Ministry of Health approved the first Russian original PD-1 inhibitor  Forteca®…

5 years ago

Promega Biotech India Private Ltd. and CORE Diagnostics, India Enter into Technology Collaboration

New Delhi, August 26, 2018: Promega Biotech India Private Ltd., a 100% subsidiary of Promega Corporation USA, a leader in…

6 years ago